Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
$CRO/USDT 4h (#Bybit) Head and Shoulders breakdown
CROUSDT Perpetual Contract
Short
$CRO/USDT 4h (#Bybit) Head and Shoulders breakdown
By TradingOn
Follow
Follow
Updated
Mar 2, 2022
0
Feb 14, 2022
⚡️⚡️ #CRO/USDT ⚡️⚡️
Exchanges: ByBit USDT
Signal Type: Regular (Short)
Leverage: Isolated (5.0X)
Current Price:
0.48070
Entry Zone:
0.48675 - 0.49725
Take-Profit Targets:
1) 0.46785
2) 0.44965
3) 0.42945
Stop Targets:
1) 0.51220
CryptoCom Coin lost 50MA support and is likely to retest it before further retracement down.
Risk/Reward= 1:1.2 | 1:2.1 | 1:3.1
Expected Profit= +24.55% | +43.05% | +63.55%
Possible Loss= -20.55%
Fib. Retracement= 0.441 | 0.559 | 0.702
Margin Leverage= 5x
Estimated Gain-time= 10 days
Tags: #CROUSDT #Cronos #CEx #Payment #App #Earn #Wallet #DeFi #SolEco
Website:
crypto.com
Contracts:
#Mainnet
#ERC20 0xa0b73e1ff0b80914ab6fe0444e65848c4c34450b
#SPL DvjMYMVeXgKxaixGKpzQThLoG98nc7HSU7eanzsdCboA
#Cosmos IBC/E6931F78057F7CC5DA0FD6CEF82FF39373A6E0452BF1FD76910B93292CF356C1
Feb 17, 2022
Trade active
All entries filled
CryptoCom Coin got rejected on supply zone as expected and is heading towards targets now.
Feb 17, 2022
Trade closed: target reached
TP1 reached with +25.55% (5x) and +1.2R
CryptoCom Coin broke-down the ascending TL and lost 100EMA support!
Bearish continuation is in play, SL adjusted to highest entry anyway (0.49725)
Mar 2, 2022
Trade closed: target reached
TP2 reached with +43.05% (5x) and +2.1R
CryptoComCoin continued bearish, SL moved to lowest entry now (0.48675)
Mar 2, 2022
Trade closed: target reached
TP3 was reached with +63.55%% (5x) and +3.1R
CryptoComCoin dumped so much more than expected, we hope that helped you not to suffer the downtrend too much!
CRO
Head and Shoulders
Trend Analysis
TradingOn
Follow
Also on:
Related publications
$CRO/USDT 1D (KuCoin) Falling wedge breakout and retest
by TradingOn
#CRO/USDT 1W (Bybit) inverted Head & Shoulders breakout & retest
by TradingOn
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.